Scribe Inks CRISPR Gene-Editing Deal with Prevail

The video discusses the CRISPR by design approach, pioneered by Jennifer Doudna and Scribe, focusing on molecular engineering for safer therapeutics. It highlights a partnership with Eli Lilly to apply this technology in neurological diseases. The rapid advancements in CRISPR technology and its potential to revolutionize medicine are explored, along with the challenges and timelines for its application. The video also touches on global collaboration and regulatory aspects, emphasizing the role of powerful universities like UC Berkeley in advancing this field.

In what ways has CRISPR technology advanced in the past decade according to the speaker?

What role do universities in the United States play in the development of CRISPR technology?